Singapore markets closed

Straits Times Index
3,296.89
+4.20(+0.13%)
S&P 500
5,041.88
+23.49(+0.47%)
Dow
38,126.09
+222.80(+0.59%)
Nasdaq
15,731.97
+126.49(+0.81%)
Bitcoin USD
59,259.47
+2,312.08(+4.06%)
CMC Crypto 200
1,275.47
+4.73(+0.37%)

ABT Sep 2024 55.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0500

0.0000

(0.00%)

As of 10:21AM EDT. Market open.

Zacks
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.